Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 13, 2014 - Issue 6
Submit an article Journal homepage
1,125
Views
12
CrossRef citations to date
0
Altmetric
Drug Safety Evaluations

Drug safety evaluation of naltrexone/bupropion for the treatment of obesity

Jessica L VerpeutRutgers, The State University of New Jersey, Department of Animal Sciences and Graduate Program in Endocrinology and Animal, Biosciences, 84 Lipman Drive, New Brunswick, NJ 08901, USA+1 848 932 2966; +1 732 932 6996; [email protected]
&
Nicholas T BelloRutgers, The State University of New Jersey, Department of Animal Sciences and Graduate Program in Endocrinology and Animal, Biosciences, 84 Lipman Drive, New Brunswick, NJ 08901, USA+1 848 932 2966; +1 732 932 6996; [email protected];Rutgers, The State University of New Jersey, New Jersey Institute for Food, Nutrition, and Health, New Brunswick, NJ 08901, USA
, PhD
Pages 831-841 | Published online: 28 Apr 2014

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (8)

João Mauricio Castaldelli-Maia, Victoria Camargos de Oliveira, Flávia Mariana Irber, Israel K. Blaas, Bernard Angerville, Anderson Sousa Martins-da-Silva, Gislaine Koch Gimenes, Marcela Waisman Campos, Julio Torales, Antonio Ventriglio, Carine Guillois, Houria El Ouazzani, Léna Gazaix, Pascal Favré, Alain Dervaux & Gisèle Apter. (2023) Psychopharmacology of smoking cessation medications: focus on patients with mental health disorders. International Review of Psychiatry 0:0, pages 1-21.
Read now
Nicholas T. Bello. (2019) Update on drug safety evaluation of naltrexone/bupropion for the treatment of obesity. Expert Opinion on Drug Safety 18:7, pages 549-552.
Read now
Rosa A. S. Couto, Luís Moreira Gonçalves, Félix Carvalho, José A. Rodrigues, Cecília M. P. Rodrigues & M. Beatriz Quinaz. (2018) The Analytical Challenge in the Determination of Cathinones, Key-Players in the Worldwide Phenomenon of Novel Psychoactive Substances. Critical Reviews in Analytical Chemistry 48:5, pages 372-390.
Read now
Bruno Halpern & Marcio C. Mancini. (2017) Safety assessment of combination therapies in the treatment of obesity: focus on naltrexone/bupropion extended release and phentermine-topiramate extended release. Expert Opinion on Drug Safety 16:1, pages 27-39.
Read now
Juliet D. Gotthardt & Nicholas T. Bello. (2016) Can we win the war on obesity with pharmacotherapy?. Expert Review of Clinical Pharmacology 9:10, pages 1289-1297.
Read now
Brian Tomlinson, Miao Hu, Yuzhen Zhang, Paul Chan & Zhong-Min Liu. (2016) Investigational glucagon-like peptide-1 agonists for the treatment of obesity. Expert Opinion on Investigational Drugs 25:10, pages 1167-1179.
Read now
Marcelo Piquet-Pessôa & Leonardo F. Fontenelle. (2016) Opioid antagonists in broadly defined behavioral addictions: a narrative review. Expert Opinion on Pharmacotherapy 17:6, pages 835-844.
Read now
Khawla F Ali, Alpana P Shukla & Louis J Aronne. (2016) Bupropion-SR plus naltrexone-SR for the treatment of mild-to-moderate obesity. Expert Review of Clinical Pharmacology 9:1, pages 27-34.
Read now

Articles from other publishers (4)

Alok K. Paul, Rownak Jahan, Anita Paul, Tooba Mahboob, Tohmina A. Bondhon, Khoshnur Jannat, Anamul Hasan, Veeranoot Nissapatorn, Polrat Wilairatana, Maria de Lourdes Pereira, Christophe Wiart & Mohammed Rahmatullah. (2022) The Role of Medicinal and Aromatic Plants against Obesity and Arthritis: A Review. Nutrients 14:5, pages 985.
Crossref
Agni Kakouri, Georgia Kanti, Efthymios Kapantais, Alexandros Kokkinos, Leonidas Lanaras, Paul Farajian, Christos Galanakis, Georgios Georgantopoulos, Nikos F. Vlahos, George Mastorakos, Alexandra Bargiota & Georgios Valsamakis. (2021) New Incretin Combination Treatments under Investigation in Obesity and Metabolism: A Systematic Review. Pharmaceuticals 14:9, pages 869.
Crossref
Angeliki Siamidi, Aikaterini Dedeloudi & Marilena Vlachou. (2021) Probing the Release of Bupropion and Naltrexone Hydrochloride Salts from Biopolymeric Matrices of Diverse Chemical Structures. Polymers 13:9, pages 1456.
Crossref
Hermann Toplak, Euan Woodward, Volkan Yumuk, Jean-Michel Oppert, Jason C.G. Halford & Gema Frühbeck. (2015) 2014 EASO Position Statement on the Use of Anti-Obesity Drugs. Obesity Facts 8:3, pages 166-174.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.